2020•Experimental Eye ResearchRequires access

EPZ015666, a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an antitumour effect in retinoblastoma

Xing Liu, Jianzhong He, Longbing Mao, Yanyan Zhang, Wenwen Cui, Sujuan Duan, Alan Jiang, Yang Gao, Yi Sang, Guofu Huang

Open publisher page 22 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 22 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Protein arginine methyltransferase 5, Retinoblastoma, Retinoblastoma protein, Cancer research, Cell cycle, Cell growth, Methyltransferase, Cell cycle checkpoint

Back to paper search Browse research topics Original source

EPZ015666, a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an antitumour effect in retinoblastoma — Research Paper | ScholarLens